A long while ago I found myself in a lecture theatre listening to a speaker arguing that lowering drug prices was a foolish policy objective. When it comes to industrial strategy, what companies need are high margins! After all, this is how you get a high quantity of gross value added, and accumulating GVA isContinue reading "Innovation, Competition, and Pitfalls of the Sector method"
